Evidence map›Paper›PMID 22762936›Full record

Trial reportJournal of critical care2012

Nonpharmacologic approach to minimizing shivering during surface cooling: a proof of principle study.

Nirav G Shah, Mark J Cowan, Edward Pickering, Houtan Sareh, Majid Afshar, Dawn Fox, Jennifer Marron, Jennifer Davis, Keith Herold, Carl B Shanholtz and 1 more

2 registry-linked trialsAbstract readClinical Trial
In one paragraph

Trial report in Journal of critical care, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03376854 phase2withdrawnnot on this mapstarted 2018, after this paper: background citation

Pilot Randomized Clinical Trial of Therapeutic Hypothermia Plus Neuromuscular Blockade vs. Standard of Care in COVID-19 Patients With Moderate to Severe ARDS - the Cooling to Help Injured Lungs (CHILL) Pilot Study

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2018 to 2021Enrolled0ConditionsRespiratory Distress Syndrome, Adult, Sars-CoV2ArmsHypothermia, Neuromuscular Blocking Agents, Standard of Care
NCT04545424 phase2recruitingnot on this mapstarted 2021, after this paper: background citation

Cooling to Help Injured Lungs (CHILL) Phase IIB Randomized Control Trial of Therapeutic Hypothermia in Patients With ARDS

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2021 to 2026Enrolled340ConditionsRespiratory Distress Syndrome, AdultArmsHypothermia, Neuromuscular Blocking Agents, Standard of care
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Should we treat pyrexia? And how do we do it?Critical care (London, England) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Nirav G ShahPulmonary and Critical Care Medicine Division, Department of Medicine and the General Clinical Research Center, University of Maryland School of Medicine, and the Baltimore VA Medical Center, MD 21201, USA.
Mark J Cowan
Edward Pickering
Houtan Sareh
Majid Afshar
Dawn Fox
Jennifer Marron
Jennifer Davis
Keith Herold
Carl B Shanholtz
Jeffrey D Hasday
University of Maryland, College Park · USUniversity of Maryland, Baltimore · USBaltimore VA Medical Center · US

Funding

p38MAP kinase-dependent mechanisms of fever-enhanced acute lung injuryR01HL069057 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI HASDAY, JEFFREY D, SHAPIRO, PAUL S · 2003 to 2016
$4.6M
The contribution of heat shock/stress pathways to acute lung injuryR01HL085256 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI HASDAY, JEFFREY D · 2007 to 2010
$1.4M
Mechanisms of HSF1-mediated Repression of TNF-alphaR01GM066855 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI HASDAY, JEFFREY D · 2004 to 2007
$1.4M
NHLBI NIH HHS HL085256NHLBI NIH HHS HL69057NHLBI NIH HHS R01 HL069057NHLBI NIH HHS R01 HL085256NIGMS NIH HHS R01 GM066855
6 · The paper itself

Abstract

purposeThis study had 2 objectives: (1) to quantify the metabolic response to physical cooling in febrile patients with systemic inflammatory response syndrome (SIRS) and (2) to provide proof for the hypothesis that the efficiency of external cooling and the subsequent shivering response are influenced by site and temperature of surface cooling pads.

methodsTo quantify shivering thermogenesis during surface cooling for fever, we monitored oxygen consumption (VO(2)) in 6 febrile patients with SIRS during conventional cooling with cooling blankets and ice packs. To begin to determine how location and temperature of surface cooling influence shivering, we compared 5 cooling protocols for inducing mild hypothermia in 6 healthy volunteers.

resultsIn the patients with SIRS, core temperature decreased 0.67 °C per hour, all patients shivered, VO(2) increased 57.6%, and blood pressure increased 15% during cooling. In healthy subjects, cooling with the 10 °C vest was most comfortable and removed heat most efficiently without shivering or VO(2) increase. Cooling with combined vest and thigh pads stimulated the most shivering and highest VO(2) and increased core temperature. Reducing vest temperature from 10 °C to 5 °C failed to increase heat removal secondary to cutaneous vasoconstriction. Capsaicin, an agonist for the transient receptor potential cation channel subfamily V member 1 (TRPV1) warm-sensing channels, partially reversed this effect in 5 subjects.

conclusionsOur results identify the hazards of surface cooling in febrile critically ill patients and support the concept that optimization of cooling pad temperature and position may improve cooling efficiency and reduce shivering.

Indexed as

Body TemperatureCritical IllnessShiveringFeverHemodynamicsHumansOxygen ConsumptionSkinSystemic Inflammatory Response SyndromeTime Factors

Identifiers

PMID22762936
PMCPMC3494806
OpenAlexW2082871902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.